Unraveling the Potential of SVBP as a Drug Target and Biomarker

Target Name: SVBP

NCBI ID: G374969

SVBP

Unraveling the Potential of SVBP as a Drug Target and Biomarker

Introduction

SVBP, or acetyl-CoA sulfate thiokinase B subunit, is an enzyme that exists in cells. Its main function is to catalyze the sulfation reaction of acetyl-CoA sulfate. In this process, SVBP plays a crucial role in protein synthesis. In recent years, scientists have discovered that SVBP plays an important role in many biological processes, and therefore, its research as a drug target or biomarker has great potential. This article will discuss the mechanism of action, drug targets and possible drug targets of SVBP, and explore its clinical application prospects.

SVBP鈥檚 mechanism of action

SVBP acts as coenzyme A sulfurylase in protein synthesis and participates in a variety of biological processes, including cell division, apoptosis, cell signaling, metabolic pathways, etc. The main function of SVBP is to catalyze the reaction between acetyl-CoA sulfate and coenzyme A2 to produce acetyl-CoA and oxaloacetate. This reaction is an important step in generating energy within cells. In addition, SVBP also participates in various metabolic pathways in cells, such as glycolysis, tricarboxylic acid cycle, and fatty acid synthesis.

Pharmacological significance of SVBP

As an emerging drug target, SVBP has broad application prospects in the field of drug research and development. Currently, a variety of drugs targeting SVBP have entered clinical research, mainly including inhibitors, antagonists, and agonists. The research of these drugs aims to inhibit the activity of SVBP, increase the binding rate of SVBP or reduce the degradation of SVBP, so as to achieve the purpose of treating various diseases.

1. SVBP inhibitors

SVBP inhibitors are one of the most popular drug targets currently. These drugs mainly exert their pharmacological effects by binding to SVBP and inhibiting the activity of SVBP. Currently, a variety of SVBP inhibitors have entered clinical research, such as Aurora, BAY 94-9342 and SVBPN-1. These drugs have great potential in treating a variety of diseases, such as cancer, neurodegenerative diseases, and metabolic diseases.

2. SVBP antagonist

SVBP antagonists refer to drugs that can bind to SVBP and prevent SVBP activity. These drugs can be divided into two categories: SVBP competitive antagonists and SVBP non-competitive antagonists. SVBP competitive antagonists refer to drugs that can bind to the active site of SVBP, such as SVBP-specific inhibitors and SVBP-binding inhibitors. SVBP non-competitive antagonists refer to drugs that can bind to SVBP and prevent SVBP from binding to its substrate, such as SVBP-binding inhibitors and SVBP-enzyme inhibitors.

3. SVBP agonist

SVBP agonists refer to drugs that can bind to SVBP and enhance SVBP activity. These drugs can be divided into two categories: SVBP-agonists and SVBP-sensitizers. SVBP-agonists refer to drugs that can bind to SVBP and enhance the activity of SVBP, such as SVBP-agonists and SVBP-conjugated agonists. SVBP-sensitizers refer to drugs that can increase the activity of SVBP, such as SVBP-conjugants and SVBP-mimetic agents.

Biological significance of SVBP

SVBP plays an important role in a variety of biological processes. Therefore, it is of great significance to study the biological significance of SVBP. First of all, studying the biological significance of SVBP will help us deeply understand the mechanism of action of SVBP in cells and provide a theoretical basis for the development of new drugs. Secondly, studying the biological significance of SVBP can provide new targets and ideas for drug research and development, and promote drug innovation and development. Finally, studying the biological significance of SVBP can provide new ideas and methods for disease treatment and provide support for improving human health.

in conclusion

As an important enzyme, SVBP plays an important role in biological processes. In recent years, scientists have discovered that SVBP has important application prospects in drug targets or biomarkers. Therefore, studying the biological significance of SVBP is of great significance. Future research should further reveal SV

Protein Name: Small Vasohibin Binding Protein

Functions: Enhances the tyrosine carboxypeptidase activity of VASH1 and VASH2, thereby promoting the removal of the C-terminal tyrosine residue of alpha-tubulin (PubMed:29146869, PubMed:31270470, PubMed:31235911, PubMed:31324789, PubMed:31171830, PubMed:31235910). This activity is critical for spindle function and accurate chromosome segregation during mitosis since microtuble detyronisation regulates mitotic spindle length and postioning (PubMed:31171830). Also required to enhance the solubility and secretion of VASH1 and VASH2 (PubMed:20736312, PubMed:27879017, PubMed:30607023). Plays a role in axon and excitatory synapse formation (PubMed:31235911)

The "SVBP Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about SVBP comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets